Your monthly Enjaymo cost savings if eligible
If you are eligible for the Enjaymo patient assistance program you can receive your medication for free. Our monthly service fee of $49 per medication covers the cost of our services in applying for the program and requesting your ongoing refills on your behalf. If you obtain your Enjaymo through NiceRx, you will only pay $49 a month regardless of the retail price of your medication.
Am I eligible for the Enjaymo patient assistance program?
You could receive your Enjaymo without paying the full retail price if you meet the eligibility criteria for assistance. The eligibility requirements are set by the pharmaceutical companies that are providing assistance programs. At NiceRx, we review each application individually, although the main factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for Enjaymo patient assistance?
We do everything that we can to take the hassle and stress out of applying for patient assistance programs. Simply start by filling in our enrollment application. We will ask for details about your healthcare provider, your insurance, and your household income. This information is required by the pharmaceutical companies you are applying to for assistance. We may also be able to help you access patient assistance for other medications that you have been prescribed, so be sure to tell us about any medications you are taking as well as Enjaymo.
NiceRx will review the information you have provided, and if we determine that you may be eligible for assistance, we will seek to enroll you in the Enjaymo patient assistance program. We will handle the enrollment process for you by working with your healthcare provider and preparing all the required paperwork for your doctor to sign. We will also request your Enjaymo medication refills on your behalf for up to 1 year once you are enrolled in the program.
Is NiceRx an Enjaymo coupon provider?
At NiceRx, we help eligible individuals access the Enjaymo patient assistance program. This means that we are not an Enjaymo coupon, an Enjaymo discount card, or an Enjaymo copay card provider. We do not offer any medication trial offers, or free Enjaymo samples.
Can NiceRx help me get Enjaymo cheaper if I have insurance?
We may be able to help you if you have insurance, including if your insurance company will not pay for your Enjaymo medication, or if you have a high copay or coinsurance responsibility. We may even be able to assist if you do not have insurance. Please fill in our enrollment application to find out more.
How much does Enjaymo cost without insurance?
Enjaymo costs without insurance will vary depending on how much you buy and the retailer you buy it from. As a guide, Enjaymo intravenous solution (jome 1100 mg/22 mL) will typically cost around $1,900 for 22 milliliters. If you obtain your medication through NiceRx, you will pay a flat monthly rate of $49 per medication regardless of its retail price.
How much does Enjaymo cost with insurance?
The copay of Enjaymo will vary in line with the specific terms of your healthcare plan. For further details about what you may need to pay, your insurance provider or pharmacist will be able to calculate the copay costs with your current insurance.
What is Enjaymo?
Enjaymo is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Sanofi. Enjaymo received FDA Breakthrough Therapy and Orphan Drug designation, and priority review. These are reserved for medicines with FDA approval that would represent significant improvements in safety or efficacy for treating serious conditions.
Cold agglutinin disease (CAD) is an autoimmune disorder where there is a destruction of red blood cells (hemolysis), leading to anemia and cold-induced symptoms, such as pain and discoloration of fingers or toes. Symptoms of CAD include tiredness, weakness, shortness of breath, fast heart rate, dizziness, and chest pain. Patients with CAD need red blood cell transfusions to manage their disease. Enjaymo is a complement inhibitor used in CAD patients to reduce the need for blood transfusions.
What doses of Enjaymo are available?
Enjaymo is available in injection form, in the following doses: 1,100 mg/22 mL (50 mg/mL) in a single-dose vial.
Your dosage will be based on your body weight. Patients weighing 39 kg to less than 75 kg will receive 6,500 mg by intravenous infusion. Patients weighing 75 kg or more will receive 7,500 mg by intravenous infusion.
Please see the full prescribing information and always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Enjaymo active ingredients
Enjaymo contains sutimlimab-jome, a type of biologic called a monoclonal antibody, as the active ingredient. Enjaymo prevents the activation of the complement cascade in the immune system and C1-activated hemolysis in CAD, thereby stopping the destruction of healthy red blood cells.
Enjaymo side effects
The most common side effects of Enjaymo in clinical trials include:
- Respiratory tract infection
- Viral infection
- Arthralgia, arthritis
- Peripheral edema
In rare instances, Enjaymo can cause more serious side effects. These can include:
- Serious Infections – vaccinate against encapsulated bacteria before treatment begins
- Infusion-related reactions
- Autoimmune disease
- Recurrent hemolysis – after discontinuation or interruption of treatment monitor patients for signs and symptoms of hemolysis
Your doctor will assess the benefits of using Enjaymo against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Enjaymo to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Enjaymo drug interactions
Other drugs may interact with Enjaymo, including prescription drugs and over-the-counter medicines, vitamins, and herbal products. Tell your health care provider about all of your medication including any supplements you are taking.
You should not use Enjaymo if you:
- Are allergic to the active ingredient sutimlimab-jome
- Are allergic to any of the other inactive ingredients in Enjaymo
Talk to your doctor before using Enjaymo if you:
- Are taking any of the medications that could interact with Enjaymo
- Have a fever or infection, including a history of human immunodeficiency virus (HIV), hepatitis B, or hepatitis C
- Have an autoimmune disease such as systemic lupus erythematosus
- Are pregnant or are planning to become pregnant
- Are breastfeeding or are planning to breastfeed
Enjaymo is the trademark brand name for sutimlimab-jome manufactured by Sanofi. A generic version of sutimlimab-jome is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Enjaymo savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.